Zhongjie Liang

Zhongjie Liang

Auto-generated profile, based on publicly available information

Zhongjie Liang

Department of Neonatology The Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University Zhejiang People's Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XWXinye Wang
Xinye Wang
RHRan Huo
Ran Huo
ZLZhongjie Liang
Zhongjie Liang
CXCongcong Xu
Congcong Xu
TCTingting Chen
Tingting Chen
SCShangqin Chen
Shangqin Chen
Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly found in premature infants. Excessive inflammation and oxidative stress contribute to BPD occurrence and development. Simvastatin, as an inhibitor of HMG‐CoA reductase, has been reported to have antioxidative and anti‐inflammatory effects. However, its effect and possible mechanisms in hyperoxia‐induced lung injury are rarely reported. In this study, in vivo and in vitro experiments were conducted to investigate whether simvastatin could ameliorate hyperoxia‐induced lung injury and explore its potential mechanism. For the in vivo study, simvastatin could improve alveolar development after hyperoxic lung injury and reduce hyperoxic stress and inflammation. The in vitro study revealed that simvastatin can reduce inflammation in A549 cells after high‐oxygen exposure. Simvastatin suppressed NLRP3 inflammasome activation and played anti‐inflammatory and antioxidant roles by increasing KLF2 (Krüppel‐like factor 2) expression. In vitro experiments also revealed that these effects of simvastatin were partially reversed by KLF2 shRNA, indicating that KLF2 was involved in simvastatin effects. In summary, our findings indicate that simvastatin could downregulate NLRP3 inflammasome activation and attenuate lung injury in hyperoxia‐induced bronchopulmonary dysplasia via KLF2‐mediated mechanism.

19 January 2026 in The FASEB Journal
Verified
Journal Article
Closed access
ZLZhongjie Liang
Zhongjie Liang
CSChengxi Shen
Chengxi Shen
JZJunyan Zeng
Junyan Zeng
XWXingling Wei
Xingling Wei
JWJinling Wei
Jinling Wei
QWQian Wang
Qian Wang